Literature DB >> 11557475

High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

Y H Yau1, B Ho, N S Tan, M L Ng, J L Ding.   

Abstract

Factor C protein isolated from the horseshoe crab, Carcinoscorpius rotundicauda, has endotoxin binding capability. Synthetic peptides of 34 amino acids based on the sequence of two regions of factor C (Sushi 1 and Sushi 3) as well as their corresponding mutants exhibited activities against 30 clinical isolates of Pseudomonas aeruginosa. Collectively, all four peptides demonstrated exceptionally effective bactericidal activity against P. aeruginosa with 90% minimal bactericidal concentrations (MBC(90)s) in the range of 0.06 to 0.25 microg/ml (16 to 63 nM). Viable bacteria were reduced by 90% after 7 min and were totally eradicated within 40 to 50 min. These peptides are minimally hemolytic against both rabbit and human erythrocytes even at concentrations up to 1,600-fold their MBC(90)s. Both in vitro and in vivo studies indicate that cytotoxic effects are small even at 1,000-fold their MBC(90)s. Furthermore, the Sushi peptides are tolerant of high-salt and adverse pH conditions. These findings demonstrate the promising therapeutic potential of the Sushi peptides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557475      PMCID: PMC90737          DOI: 10.1128/AAC.45.10.2820-2825.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Detection of genes encoding aminoglycoside-modifying enzymes in staphylococci by polymerase chain reaction and dot blot hybridization.

Authors:  E E Udo; A A Dashti
Journal:  Int J Antimicrob Agents       Date:  2000-02       Impact factor: 5.283

Review 2.  Mode of action of linear amphipathic alpha-helical antimicrobial peptides.

Authors:  Z Oren; Y Shai
Journal:  Biopolymers       Date:  1998       Impact factor: 2.505

3.  Nosocomial infections caused by multiresistant Pseudomonas aeruginosa.

Authors:  E A Arruda; I S Marinho; M Boulos; S I Sinto; H H Caiaffa; C M Mendes; C P Oplustil; H Sader; C E Levy; A S Levin
Journal:  Infect Control Hosp Epidemiol       Date:  1999-09       Impact factor: 3.254

Review 4.  The molecular pathogenesis of endotoxic shock and organ failure.

Authors:  R Karima; S Matsumoto; H Higashi; K Matsushima
Journal:  Mol Med Today       Date:  1999-03

5.  Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.

Authors:  S Y Shin; J H Kang; K S Hahm
Journal:  J Pept Res       Date:  1999-01

6.  In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.

Authors:  A Giacometti; O Cirioni; F Barchiesi; M Fortuna; G Scalise
Journal:  J Antimicrob Chemother       Date:  1999-11       Impact factor: 5.790

7.  In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens.

Authors:  U Schwab; P Gilligan; J Jaynes; D Henke
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

8.  SMAP-29: a potent antibacterial and antifungal peptide from sheep leukocytes.

Authors:  B Skerlavaj; M Benincasa; A Risso; M Zanetti; R Gennaro
Journal:  FEBS Lett       Date:  1999-12-10       Impact factor: 4.124

9.  Evaluation of antimicrobial and lipopolysaccharide-neutralizing effects of a synthetic CAP18 fragment against Pseudomonas aeruginosa in a mouse model.

Authors:  T Sawa; K Kurahashi; M Ohara; M A Gropper; V Doshi; J W Larrick; J P Wiener-Kronish
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

10.  OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.

Authors:  F Danel; L M Hall; D Gur; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more
  6 in total

1.  De novo design of potent antimicrobial peptides.

Authors:  V Frecer; B Ho; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

2.  Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities.

Authors:  S P Liu; L Zhou; R Lakshminarayanan; R W Beuerman
Journal:  Int J Pept Res Ther       Date:  2010-08-26       Impact factor: 1.931

Review 3.  Current treatment of pseudomonal infections in the elderly.

Authors:  Georgios Pappas; Kaiti Saplaoura; Matthew E Falagas
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Recombinant Tandem Repeated Expression of S3 and SΔ3 Antimicrobial Peptides.

Authors:  Sadegh Rezaei; Shahin Hadadian; Ramazan Ali Khavari-Nejad; Dariush Norouzian
Journal:  Rep Biochem Mol Biol       Date:  2020-10

5.  Antimicrobial activity of Tachyplesin 1 against Burkholderia pseudomallei: an in vitro and in silico approach.

Authors:  Lyn-Fay Lee; Vanitha Mariappan; Kumutha Malar Vellasamy; Vannajan Sanghiran Lee; Jamuna Vadivelu
Journal:  PeerJ       Date:  2016-10-25       Impact factor: 2.984

Review 6.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.